Projects per year
Personal profile
Education/Academic qualification
Doctor of Pharmacy, Université de Liège (ULg)
Award Date: 30 Jun 2000
Fingerprint Dive into the research topics where Jean-Michel DOGNE is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 12 Similar Profiles
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects
The HIC Project - evaluation of hormone-induced coagulopathy
DOGNE, J., DOUXFILS, J. & Morimont, L.
1/09/19 → …
Project: PHD
The CAF project - a new tool for the assessment of the clot formation
DOUXFILS, J., DOGNE, J. & Evrard, J.
1/09/18 → …
Project: Research
BIOMED HUB-AVRI: Artériopathie et Valvulopathie Radio-Induites Un nouveau défi pour la médecine moderne
1/06/17 → 31/12/20
Project: Research
Implication of microparticles in thrombosis associated with paroxysmal nocturnal hemoglobinuria
Chatelain, B., Chatelain, C. & DOGNE, J.
1/12/13 → …
Project: Research
Research Output
Clinical performance of the Elecsys electrochemiluminescent immunoassay for the detection of SARS-CoV-2 total antibodies
Favresse, J., Eucher, C., Elsen, M., Marie, T-H., Dogné, J-M. & Douxfils, J., 2020, In : Clinical Chemistry. 7 p.Research output: Contribution to journal › Article
File
Evaluation of the analytical performances of FibWave, a new sensitive tool assessing the fibrin clot formation, to measure the effects of anticoagulants
Evrard, J., Morimont, L., Benyahia, Z., Laloy, J., Siriez, R., Dogné, J. M. & Douxfils, J., Jul 2020, In : Thrombosis Research. 191, p. 78-81 4 p.Research output: Contribution to journal › Letter
Il faut rappeler que le 'risque zéro' n’existe pas: chronique 3 - covid-19
Flohimont, V., DOGNE, J-M. & FAUVILLE, MARIE-ALINE. (ed.), 4 May 2020, HR Square.Research output: Book/Report/Journal › Commissioned report
Open Access
File
3
Downloads
(Pure)
Importance of measuring pharmacologically active metabolites of edoxaban: development and validation of an ultra-high-performance liquid chromatography coupled with a tandem mass spectrometry method
Siriez, R., Alpan, L., Elasaad, K., Devel, P., Laloy, J., Dogne, J-M. & Douxfils, J., 1 Apr 2020, In : Journal of Thrombosis and Thrombolysis. 49, 3, p. 395-403 9 p.Research output: Contribution to journal › Article
Long-Term Survival, Vascular Occlusive Events and Efficacy Biomarkers of First-Line Treatment of CML: A Meta-Analysis
Haguet, H., Graux, C., Mullier, F., Dogné, J-M. & Douxfils, J., 15 May 2020, In : Cancers. 12, 5, 15 p., 1242.Research output: Contribution to journal › Article
File
Datasets
CCDC 1017214: Experimental Crystal Structure Determination
Damas, J. (Contributor), de Leval, X. (Contributor), DOGNE, J. (Contributor), Julémont, F. (Contributor), Michaux, C. (Contributor), MONTERO, J. (Contributor), Pirotte, B. (Contributor), Renard, J. (Contributor) & WINUM, J. (Contributor), Cambridge Crystallographic Data Centre, 1 Jan 2014
DOI: 10.5517/cc134hc3, http://www.ccdc.cam.ac.uk/services/structure_request?id=doi:10.5517/cc134hc3&sid=DataCite
Dataset
Risk of arterial and venous occlusive events in chronic myeloid leukemia patients treated with new generation BCR-ABL tyrosine kinase inhibitors: a systematic review and meta-analysis
Graux, C. (Contributor), CHATELAIN, C. (Contributor), MULLIER, F. (Contributor), Haguet, H. (Contributor), DOGNE, J. (Contributor) & DOUXFILS, J. (Contributor), Figshare, 29 Nov 2016
DOI: 10.6084/m9.figshare.4265168.v1, https://figshare.com/articles/Risk_of_arterial_and_venous_occlusive_events_in_chronic_myeloid_leukemia_patients_treated_with_new_generation_BCR-ABL_tyrosine_kinase_inhibitors_a_systematic_review_and_meta-analysis/4265168/1 and one more link, https://ndownloader.figshare.com/files/6948968 (show fewer)
Dataset
CCDC 1017215: Experimental Crystal Structure Determination
Damas, J. (Contributor), de Leval, X. (Contributor), DOGNE, J. (Contributor), Julémont, F. (Contributor), Michaux, C. (Contributor), MONTERO, J. (Contributor), Pirotte, B. (Contributor), Renard, J. (Contributor) & WINUM, J. (Contributor), Cambridge Crystallographic Data Centre, 1 Jan 2014
DOI: 10.5517/cc134hd4, http://www.ccdc.cam.ac.uk/services/structure_request?id=doi:10.5517/cc134hd4&sid=DataCite
Dataset
Prizes
Prix Léo Pharma Cancer & Thrombosis
Haguet, Helene (Recipient), DOUXFILS, JONATHAN (Recipient), MULLIER, Francois (Recipient) & DOGNE, Jean-Michel (Recipient), 25 Feb 2017
Prize: Prize (including medals and awards)
Activities
- 6 Oral presentation
Mécanismes thrombotiques des inhibiteurs de tyrosine kinase ciblant BCR-ABL
Hélène Haguet (Speaker), , Jonathan Douxfils (Speaker), , François Mullier (Speaker), , Christian Chatelain (Speaker), , Carlos Graux (Speaker), & Jean-Michel Dogne (Speaker)
21 Mar 2019
Activity: Talk or presentation types › Oral presentation
In vitro effects of BCR-ABL TKIs on endothelial cell survival and functions
Hélène Haguet (Speaker), , Jonathan Douxfils (Speaker), , Christian Chatelain (Speaker), , Carlos Graux (Speaker), , François Mullier (Speaker), & Jean-Michel Dogne (Speaker)
9 Feb 2018
Activity: Talk or presentation types › Oral presentation
Risk of vascular occlusive events with BCR-ABL TKIs in CML
Hélène Haguet (Speaker), , Jonathan Douxfils (Speaker), , François Mullier (Speaker), , Christian Chatelain (Speaker), , Carlos Graux (Speaker), & Jean-Michel Dogne (Speaker)
25 Feb 2017
Activity: Talk or presentation types › Oral presentation
Risk of vascular occlusive events with BCR-ABL TKIs in CML - A systematic review and meta-analysis
Hélène Haguet (Speaker), , Jonathan Douxfils (Speaker), , François Mullier (Speaker), , Christian Chatelain (Speaker), , Carlos Graux (Speaker), & Jean-Michel Dogne (Speaker)
28 Apr 2016
Activity: Talk or presentation types › Oral presentation
Risk of vascular occlusive events with BCR-ABL TKIs in CML - A systematic review and meta-analysis
Hélène Haguet (Speaker), , Jonathan Douxfils (Speaker), , François Mullier (Speaker), , Christian Chatelain (Speaker), , Carlos Graux (Speaker), & Jean-Michel Dogne (Speaker)
29 Jan 2016
Activity: Talk or presentation types › Oral presentation